Key To Growing Probiotic Sales: Talk Benefits, Not Bacteria
This article was originally published in The Tan Sheet
Emphasize probiotics’ benefits rather than touting research supporting claims or using the technical terms linked to bacteria strains, says Mintel’s Lynn Dornblaser. P&G.’s Meta line capitalizes on consumers’ growing affinity for probiotics with the right approach to promote the brand.
You may also be interested in...
Research on probiotics’ health benefits rapidly grows, but turning studies into label claims lags due to differences between industry, NIH and FDA about standards for claims substantiation. Attendees at a U.S. Pharmacopeia conference outline the challenges to finding common ground
Guidance extends through Jan. 6 enforcement discretion for formula products cleared for sales under temporary guidance FDA announced in May. Further extensions possible for firms taking steps toward lawful marketing of products in US, agency says.
Latest plan, agency’s second annual following debut in 2021, lists monograph activities FDA intends to address over next three years. “FDA’s decision‐making regarding which activities to place on the forecast is generally guided by public health priorities,” it says.